Rainier Investment Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Rainier Investment Management’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-513,800	Closed	-$8.51M	–	202
2016 Q1	$8.51M	Sell	513,800 -40,070	-7%	-$701K	0.38%	106
2015 Q4	$12M	Buy	553,870 +177,230	+47%	+$3.45M	0.47%	94
2015 Q3	$7.46M	Buy	+376,640	New	+$11.9M	0.27%	139
2014 Q3	–	Sell	-39,650	Closed	-$627K	–	217
2014 Q2	$627K	Sell	39,650 -46,580	-54%	-$665K	0.01%	185
2014 Q1	$1.3M	Buy	+86,230	New	+$974K	0.02%	197

Other funds holding HZNP

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

Rainier Investment Management's HZNP Position: Q2 2016 in Review

Rainier Investment Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q2 2016, closing a stake of 513,800 shares — an estimated $8.51M sold.

Rainier Investment Management first reported a position in HZNP in Q1 2014 and held it in 5 quarters. The position peaked at $12M in Q4 2015. 198 funds tracked by Wall St. Rank hold HZNP as of Q2 2016.

Rainier Investment Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q2 2016 after selling out during the quarter.
Rainier Investment Management sold 513,800 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q2 2016, an estimated $8.51M.
Rainier Investment Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2014 and held it in 5 quarters.
Rainier Investment Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $12M in Q4 2015.
198 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q2 2016.

Based on Rainier Investment Management's 13F filing for Q2 2016, filed 15 Aug 2016.